2023 Programme

09:30 – 09:35


Arnaud Thysen
Director General, European Business Summits

09:35 – 09:45

opening conversation: "fostering competition in Europe: made in the EU"

Didier Reynders
Commissioner for Justice
Andy Bounds,
Financial Times Correspondent

09:45 – 10:00

Exclusive Interview

Lars Fruergaard Jørgensen,
CEO of Novo Nordisk, President of EFPIA
Andy Bounds,
Financial Times Correspondent

10:00 – 11:00

Building a solid infrastructure for the european digital health

Tomislav Sokol
MEP Rapporteur of EHDS

Maya Matthews
Deputy Director for Digital, EU4Health and Health Systems Modernisation at DG SANTE
Enrique Terol
Health Counsellor, Spanish Representation to the EU
Dipak Kalra
President of the European Institute for Innovation through Health Data
José Peres
Senior Coordinator of the National Associations Council at EuropaBio
Menno Kok
Managing Director at EIT Health

The benefits of the EHDS are unrivalled and progress is being made towards its implementation. However, ensuring that its necessary components are in place will also be crucial. The question now centres around bolstering sufficient infrastructure, in tandem with both the public and private sectors, to ensure the highest levels of access, privacy and operability. Going a step further, this year EHS will be exploring how Artificial Intelligence (AI) can accelerate patient centricity in Europe.

11:00 – 11:15

Coffee break

11:15 – 11:30

Exclusive Interview on the Impact of Demographic Challenges in Healthcare

Colin Scicluna
Head of Cabinet of VP Suiča, European Commission

Giedre Peseckyte
Reporter, Euractiv

11:30 – 11:40

Keynote Address with Dr. Gaudenz Silberschmidt on Enhanced Partnerships for Global Health

Dr. Gaudenz Silberschmidt
Director for Health & Multilateral Partnerships WHO

11:00 – 11:15

Interview with Dr. Gaudenz Silberschmidt

Dr. Gaudenz Silberschmidt
Director for Health & Multilateral Partnerships, WHO

11:40 – 12:40

Strengthening public, private, academia, and tech partnerships to advance r&d for unmet needs

Emer Cooke
Executive Director, European Medicines Agency
Irene Norstedt
Director, People Directorate, DG Research and Innovation
Yann Le Cam
CEO, Eurordis
Adam Hacker
Director and Global Head Regulatory Affairs, CEPI
Charlotte Marchandise
Executive Director at the European Public Health Association (EUPHA)

Tamsin Rose
EU Health Reporter

For R&D to flourish and engender scientific breakthroughs, a conducive environment is needed. Some countries are beginning to create ecosystems for healthcare innovation, creating essential links between the scientific community, big tech, governments, and the public-private sectors. This will allow them to develop and operationalise new treatments in record time. How can the EU keep up with other regions and what steps are needed for a coordinated response?

12:40 – 13:40

Ensuring sustainable healthcare systems through the "One Health" approach

Laurent Muschel
Laurent Muschel
Acting Director-General, HERA
Carlos Montañés
Executive Vice President, HIPRA
Andrea Corazza
Senior Director Policy & Government Affairs Europe, Novavax

Josep Figueras
Director & Cofounder, European Observatory on Health Systems and Policies

Sara Cerdas
Member of the European Parliament

Sarah-Taïssir Bencharif
EU Health Reporter

With a global population that is both growing and ageing, health systems will come under increased pressure. By considering a wider set of contributory factors for healthcare such as healthy nutrition, sustainable food, environmental, agricultural, fisheries and climate policies, we can foster resilience. The COVID-19 pandemic, other disease outbreaks and their societal and economic costs highlight the urgency of applying a One Health approach across all sectors.

13:40 – 14:40

Networking Lunch

14:40 – 15:55

A pharma strategy to foster europe's competitiveness on the global scale?

Pernille Weiss
MEP Rapporteur Pharma Directive

Anca Toma
Executive Director of the European Patients’ Forum

Massimo Giorgio Visentin
Eastern Europe Cluster President, Pfizer

Francesca Colombo
Head of Health Division, OECD
Nathalie Moll
Director General, EFPIA
Mariam Zaidi
International News Presenter

Europe has all the ingredients to drive innovation. It is very attractive for biopharmaceuticals, and has a highly skilled workforce, as well as promising drugs and treatments, especially in the field of rare diseases. However, the pandemic has highlighted the vulnerability of our supply chains and the need to make them more resilient. Among other concerns, there is a need to reform the healthcare sector to optimise budgets and sustainability. We need real data to highlight drug efficacy and increase population and market access. Ensuring that we have the right environment for innovation, supported by strong industrial policy, is critical to continue to foster investment in Europe.

15:55 – 16:00

Strategic Competitiveness of Europe's Pharmaceutical Industry: A Member States' Perspective

Martin Kocher
Minister for Labour and Economy of Austria

Mariam Zaidi
International News Presenter

16:00 – 16:10

Coffee Break

16:10 – 17:25

Revitalising Europe's Pharmaceutical Legislation: Prioritising Patient Access and Innovation

Jeffrey Francer
VP Global Regulatory Affairs, Eli Lilly

Prof. Claire Paquet
Neurologist, Assistance Publique – Hôpitaux de Paris

Haseeb Ahmad
President, Europe at Novartis

Dolors Montserrat
Member of the European Parliament

Elizabeth Kuiper
Associate Director, European Policy Centre

Mariam Zaidi
International News Presenter

At the core of Europe’s pharmaceutical legislative reform lies a steadfast commitment to enhancing and expediting patient access to vital healthcare solutions. This unwavering dedication hinges on the level of investment in innovation across the region, encompassing various aspects such as the management of clinical trials and primary/raw data, addressing unmet medical needs, optimizing manufacturing processes for greater efficiency, and establishing a globally competitive regulatory framework coupled with prudent monitoring of supply chains.

17:30 – 17:35

Closing remarks

Giorgios Rossides,
Head of Cabinet Commissioner Kyriakides

17:25 – 17:35

Keynote address

Giorgos Rossides
Head of Cabinet Commissioner Kyriakides

17:35 – 17:40

Closing remarks

Arnaud Thysen
Director General, European Business Summits